Do Cardiovascular Risk Factors Influence Cardiac Allograft Vasculopathy?
Tài liệu tham khảo
Kobashigawa, 2000, What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?, Curr Control Trials Cardiovasc Med, 1, 166, 10.1186/CVM-1-3-166
Labarrere, 1999, Relationship of fibrin deposition in microvasculature to outcomes in cardiac transplantation, Curr Opin Cardiol, 14, 133, 10.1097/00001573-199903000-00010
Kapadia, 2000, Intravascular ultrasound imaging after cardiac transplantation: advantage of multi-vessel imaging, J Heart Lung Transplant, 19, 167, 10.1016/S1053-2498(99)00128-X
Tuzcu, 2005, Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation, J Am Coll Cardiol, 45, 1538, 10.1016/j.jacc.2004.12.076
Billingham, 1992, Histopathology of graft coronary disease, J Heart Lung Transplant, 11, S38
Lindenfeld, 2005, Drug therapy in the heart transplant recipient: Part III: common medical problems, Circulation, 111, 113, 10.1161/01.CIR.0000151609.60618.3C
Rickenbacher, 1996, Coronary artery intimal thickening in the transplanted heart. An in vivo intracoronary untrasound study of immunologic and metabolic risk factors, Transplantation, 61, 46, 10.1097/00007890-199601150-00011
Eisen, 2003, Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients, N Engl J Med, 349, 847, 10.1056/NEJMoa022171